Trend adjustment of the sequence difference when performing sequence symmetry analyses

Martin Torp Rahbek; Jesper Hallas; Lars Christian Lund

doi:10.1002/pds.5723

Trend adjustment of the sequence difference when performing sequence symmetry analyses

Martin Torp Rahbek^*, Jesper Hallas, Lars Christian Lund

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Pharmacoepidemiology and Drug Safety
Vol/bind	33
Udgave nummer	1
Antal sider	2
ISSN	1053-8569
DOI	https://doi.org/10.1002/pds.5723
Status	Udgivet - jan. 2024

Bibliografisk note

Funding Information:
Martin Torp Rahbek reports no conflicts of interest. Lars Christian Lund reports participation in research projects funded by Menarini Pharmaceuticals and LEO Pharma, all with funds paid to the institution where he was employed (no personal fees) and with no relation to the current work. Jesper Hallas reports participation in post authorization safety studies funded by Novo Nordisk with money paid to his employer and with no personal fees involved.

Dokumenter og links

10.1002/pds.5723

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{db0f946ea0ea4bb0a6c2bc7bee0d89f8,

title = "Trend adjustment of the sequence difference when performing sequence symmetry analyses",

author = "Rahbek, \{Martin Torp\} and Jesper Hallas and Lund, \{Lars Christian\}",

note = "Funding Information: Martin Torp Rahbek reports no conflicts of interest. Lars Christian Lund reports participation in research projects funded by Menarini Pharmaceuticals and LEO Pharma, all with funds paid to the institution where he was employed (no personal fees) and with no relation to the current work. Jesper Hallas reports participation in post authorization safety studies funded by Novo Nordisk with money paid to his employer and with no personal fees involved.",

year = "2024",

month = jan,

doi = "10.1002/pds.5723",

language = "English",

volume = "33",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - Trend adjustment of the sequence difference when performing sequence symmetry analyses

AU - Rahbek, Martin Torp

AU - Hallas, Jesper

AU - Lund, Lars Christian

N1 - Funding Information: Martin Torp Rahbek reports no conflicts of interest. Lars Christian Lund reports participation in research projects funded by Menarini Pharmaceuticals and LEO Pharma, all with funds paid to the institution where he was employed (no personal fees) and with no relation to the current work. Jesper Hallas reports participation in post authorization safety studies funded by Novo Nordisk with money paid to his employer and with no personal fees involved.

PY - 2024/1

Y1 - 2024/1

U2 - 10.1002/pds.5723

DO - 10.1002/pds.5723

M3 - Comment/debate

C2 - 37909327

AN - SCOPUS:85175553938

SN - 1053-8569

VL - 33

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 1

ER -